In summary, treatment of mouse models of diabetes with IL-1β- and TNF-antagonists, and with sodium salicylate improved insulin secretion and glycaemia to comparable levels, with an additive effect on insulin secretion with the combination of IL-1β- and TNFα-antagonists. The gene discussed is IL1B; the disease is diabetes mellitus.